Open Access | Peer-Reviewed | Clinical Evidence Reviews

Blue Terra Longevity Review

Vol 1, 2026|ISSN: Pending

Each article reviews published research in longevity medicine, stress physiology, and clinical wellness. All claims are cited. All sources are linked.

Editorial Board

Editor-in-Chief

Dr. Toma Babic

Medical Director, Blue Terra

Board Member

To be announced

Appointment pending

Board Member

To be announced

Appointment pending

About the Journal

Blue Terra Longevity Review is an open access, peer-reviewed journal publishing clinical evidence reviews in longevity medicine, stress physiology, burnout recovery, and preventive wellness. Every article is grounded in cited, peer-reviewed research and translated into clinically actionable language for physicians and informed practitioners.

Submission Guidelines →Open AccessCC BY 4.0

Volume 1, Issue 1 (2026)

4 articles

Clinical Wellness8 min read|BTLR-2026-004

Intravenous Glutathione and Oxidative Stress: Clinical Mechanisms and Therapeutic Applications

Oxidative stress contributes to numerous pathological conditions through mitochondrial dysfunction and cellular damage. Recent research demonstrates the critical role of antioxidant systems in neuroprotection, aging, and metabolic disorders, informing clinical applications of intravenous glutathione therapy.

glutathioneoxidative stressmitochondrial dysfunctionneuroprotection

Dr. Toma Babić·3 April 2026·8 references·DOI: 10.XXXXX/btlr.2026.004

Longevity9 min read|BTLR-2026-001

NAD+ Decline, Cellular Ageing, and the Case for IV Repletion

NAD+ levels decline by up to 50% between ages 40 and 60. The mechanistic link between this decline and cellular dysfunction is no longer speculative — but the optimal repletion strategy remains debated.

NAD+nicotinamide adenine dinucleotideIV therapycellular ageing

Dr. Toma Babić·15 March 2026·10 references·DOI: 10.XXXXX/btlr.2026.001

Clinical Wellness8 min read|BTLR-2026-002

Beyond the Standard Panel: Why 80+ Biomarkers Change the Clinical Picture

Standard GP bloodwork covers 10–15 markers designed to detect existing disease. Comprehensive panels measuring 80+ biomarkers detect subclinical dysfunction — the space between 'fine' and optimal.

biomarkerscomprehensive diagnosticssubclinical dysfunctionepigenetic age

Dr. Toma Babić·20 February 2026·10 references·DOI: 10.XXXXX/btlr.2026.002

Burnout Recovery10 min read|BTLR-2026-003

Burnout Is a Neuroendocrine Disorder, Not a Lifestyle Problem

Burnout involves measurable HPA axis dysregulation, blunted cortisol responsivity, and systemic inflammation. It is a clinical condition with a physiological basis — not a motivational failure.

burnoutHPA axiscortisolneuroendocrine

Dr. Toma Babić·28 January 2026·9 references·DOI: 10.XXXXX/btlr.2026.003

Updated Regularly

New reviews published biweekly.

Our clinical team reviews the latest peer-reviewed research in longevity medicine, stress physiology, and evidence-based recovery — and translates it into plain language.

Stay Informed

Clinical insights, once a month.

No spam. No sales. Just evidence.

Monthly clinical research reviews from our physician team. Unsubscribe anytime.